Related Experiment Video
Updated: Sep 12, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways,
Esraa Abdo Moustafa1, Nahed Nasser Eid El-Sayed1, Marwa A Fouad2,3
1Egyptian Drug Authority (EDA), Giza, Egypt.
Abstract:
Neurodegenerative disorders represent the second largest group of diseases worldwide. 2(1H)-quinolone and its structural congener, 4(1H)-quinolone have recently become significant topics in the field of drug design and development of modulators of neurotransmitter systems and neuroprotective agents to tackle neurodegenerative disorders. In this review, the structural properties and the early classical as well as the recent novel synthetic strategies for 2(1H)-/4(1H)-quinolone are discussed. The neuropharmacological activity and mechanisms of action of several 2(1H)-/4(1H)-quinolinone-based compounds are demonstrated with special emphasis on the structure-activity relationships (SAR). Therefore, the perspectives elaborated in this review could guide medicinal chemists for rational design and development of novel 2(1H)-/4(1H)-quinolone therapeutic candidates targeting neurodegenerative diseases.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Gene Regulation in Microbial Communities: Quorum Sensing
Drug Discovery: Overview
Local Anesthetics: Chemistry and Structure-Activity Relationship
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)